About Juno Bio

The startup develops a vaginal microbiome testing kit that utilizes machine learning and bioinformatics to analyze microbial compositions linked to recurrent infections and infertility. This technology enables women to gain insights into their microbiome, facilitating personalized health management and improving overall reproductive health.

```xml <problem> Many women experience recurrent vaginal infections and infertility, which can often be linked to imbalances in the vaginal microbiome, yet understanding this complex ecosystem remains challenging. Traditional diagnostic methods often provide incomplete information, leaving women without a clear understanding of their vaginal health. </problem> <solution> Juno Bio offers an at-home vaginal microbiome test that utilizes next-generation sequencing to provide a comprehensive profile of all detectable bacteria and fungi present. This advanced analysis identifies over 10,000 different species and their relative abundance, offering deeper insights compared to traditional PCR tests. Customers receive a detailed report accessible through a private online dashboard, which includes an option to book a consultation with a vaginal health expert to review the results. The test empowers women to proactively manage their vaginal wellness, understand potential causes of recurrent infections or fertility concerns, and make informed decisions about their health. </solution> <features> - At-home vaginal swab collection for easy and convenient sample acquisition - Next-generation sequencing (NGS) technology for comprehensive detection of all bacteria and fungi present - Identification of over 10,000 microbial species with 0.1% resolution - Detailed report including relative abundance of each detected species - Online dashboard for secure access to test results and personalized insights - Option to book a one-on-one consultation with a vaginal health expert - Ability to use HSA/FSA funds for test purchase - International shipping available </features> <target_audience> The primary target audience includes women and individuals with vaginas over the age of 18 who are seeking to understand their vaginal microbiome for wellness purposes, particularly those experiencing recurrent infections, fertility concerns, or (peri)menopause symptoms. </target_audience> <revenue_model> Juno Bio generates revenue through direct sales of its Vaginal Microbiome Test, offered as a single purchase for $149 or as a subscription for $99, delivered every three months. </revenue_model> ```

What does Juno Bio do?

Where is Juno Bio located?

Juno Bio is based in London, United Kingdom.

How much funding has Juno Bio raised?

Juno Bio has raised 4550000.

Location

London, United Kingdom

Funding

4550000

Employees

5 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Juno Bio

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

juno.bio 2K+

Crunchbase

London, United Kingdom

Funding

Estimated Funding

$3M+

Team (5+)

No team information available.

Company Description

Problem

Many women experience recurrent vaginal infections and infertility, which can often be linked to imbalances in the vaginal microbiome, yet understanding this complex ecosystem remains challenging. Traditional diagnostic methods often provide incomplete information, leaving women without a clear understanding of their vaginal health.

Solution

Juno Bio offers an at-home vaginal microbiome test that utilizes next-generation sequencing to provide a comprehensive profile of all detectable bacteria and fungi present. This advanced analysis identifies over 10,000 different species and their relative abundance, offering deeper insights compared to traditional PCR tests. Customers receive a detailed report accessible through a private online dashboard, which includes an option to book a consultation with a vaginal health expert to review the results. The test empowers women to proactively manage their vaginal wellness, understand potential causes of recurrent infections or fertility concerns, and make informed decisions about their health.

Features

At-home vaginal swab collection for easy and convenient sample acquisition

Next-generation sequencing (NGS) technology for comprehensive detection of all bacteria and fungi present

Identification of over 10,000 microbial species with 0.1% resolution

Detailed report including relative abundance of each detected species

Online dashboard for secure access to test results and personalized insights

Option to book a one-on-one consultation with a vaginal health expert

Ability to use HSA/FSA funds for test purchase

International shipping available

Target Audience

The primary target audience includes women and individuals with vaginas over the age of 18 who are seeking to understand their vaginal microbiome for wellness purposes, particularly those experiencing recurrent infections, fertility concerns, or (peri)menopause symptoms.

Revenue Model

Juno Bio generates revenue through direct sales of its Vaginal Microbiome Test, offered as a single purchase for $149 or as a subscription for $99, delivered every three months.